Clearline Capital’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,496,297
| Closed | -$6.07M | – | 121 |
|
|
2022
Q3 | $6.07M | Sell |
2,496,297
-421,963
| -14% | -$1.03M | 0.73% | 36 |
|
|
2022
Q2 | $5.78M | Sell |
2,918,260
-2,219,597
| -43% | -$4.39M | 0.75% | 34 |
|
|
2022
Q1 | $9.4M | Sell |
5,137,857
-1,212,837
| -19% | -$2.22M | 1.08% | 29 |
|
|
2021
Q4 | $8.95M | Buy |
6,350,694
+5,603,249
| +750% | +$7.9M | 0.98% | 30 |
|
|
2021
Q3 | $845K | Sell |
747,445
-175,072
| -19% | -$198K | 0.08% | 106 |
|
|
2021
Q2 | $1.48M | Buy |
922,517
+574,439
| +165% | +$919K | 0.22% | 78 |
|
|
2021
Q1 | $613K | Buy |
+348,078
| New | +$613K | 0.08% | 84 |
|